Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.

Metastatic bone and soft tissue sarcomas often relapse after chemotherapy (CHT) and molecular targeted therapy (mTT), maintaining a severe prognosis. A subset of sarcoma cancer stem cells (sCSC) is hypothesized to resist conventional drugs and sustain disease relapses. We investigated the immunother...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesiano, Giulia, Grignani, Giovanni, Fiorino, Erika, Leuci, Valeria, Rotolo, Ramona, D’Ambrosio, Lorenzo, Salfi, Chiara, Gammaitoni, Loretta, Giraudo, Lidia, Pisacane, Alberto, Butera, Sara, Pignochino, Ymera, Basiricó, Marco, Capozzi, Federica, Sapino, Anna, Aglietta, Massimo, Sangiolo, Dario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208452/
https://www.ncbi.nlm.nih.gov/pubmed/30393581
http://dx.doi.org/10.1080/2162402X.2018.1465161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208452/
https://www.ncbi.nlm.nih.gov/pubmed/30393581
http://dx.doi.org/10.1080/2162402X.2018.1465161

Ejemplares similares